[Posted on February 24, 2008 at 10:00 AM]
Alvarez & Marsal Business Consulting's Anthony Treccapelli and Ronald Bisaccia weigh in on the difficulties of managing technology in a carve-out in a Feb. 25 Deal newsweekly column. ...
Continue reading
|
|
[Posted on February 23, 2008 at 10:00 AM]
James D. Rosener the partner-in-charge of Pepper Hamilton LLP's New York office, argues in a Feb. 25 Deal newsweekly column that in the wake of Delaware's URI decision, buyer-seller agreements
Continue reading
|
|
[Posted on February 21, 2008 at 12:27 PM]
James D'Aquila, a managing director with midmarket-focused boutique bank Mercanti Group, examines what lies ahead for M&A in 2008, particularly on the middle-market front, in a Deal column Thursday. ...
Continue reading
|
|
[Posted on February 16, 2008 at 10:00 AM]
Lloyd Harmetz, a capital markets partner at Morrison & Foerster LLP and Deal contributor, weighs in on the SEC changes to Rules 144 and 145--the key aspects and who benefits.
Continue reading
|
|
[Posted on February 14, 2008 at 1:13 PM]
We're putting up a column Thursday in our Soapbox section on the current state of Wall Street research. The piece, by John Merriman of Merriman Curhan Ford & Co.
Continue reading
|
|
[Posted on February 13, 2008 at 4:40 PM]
Timothy Spangler, who heads Kaye Scholer LLP's investment funds group, writes for The Deal about the differing strategies to hedge fund and private equity regulation U.S. and British regulators are
Continue reading
|
|
[Posted on February 10, 2008 at 12:30 PM]
Nicolas Ulmer, a Geneva-based international arbitration lawyer with Winston & Strawn LLP and a Deal contributor, writes about the new global playing field of arbitration, the playing field that has
Continue reading
|
|
[Posted on February 9, 2008 at 9:00 AM]
Patrick J. Dooley, an M&A partner with Akin Gump Strauss Hauer & Feld LLP and a Deal contributor, looks at 2007 for hints about the M&A and private equity outlook
Continue reading
|
|
[Posted on February 7, 2008 at 3:39 PM]
In a Daily Deal column Thursday, contributors Lucantino N. Salvi (left) and Marko W. Kipa of Sheppard, Mullin, Richter and Hampton LLP tackle issues government contractors need to weigh
Continue reading
|
|
[Posted on February 7, 2008 at 12:12 PM]
The information contained in the press release describing the merger agreement entered into by Inverness Medical Innovations, Inc. and Matria Healthcare, Inc. was, as it turns out, incomplete. (See previous
Continue reading
|
|
[Posted on February 7, 2008 at 12:08 PM]
In a recent column, Robert Willens, president of Robert Willens LLC and longtime contributor to The Deal, raised questions on the $1.18 million Inverness Medical Innovations Inc.-Matria Healthcare Inc. deal,
Continue reading
|
|
[Posted on February 3, 2008 at 7:00 AM]
Peter Hockless, a Debevoise & Plimpton LLP private equity partner, discusses the material adverse change clause in the U.K. ...
Continue reading
|
|
[Posted on February 2, 2008 at 7:00 AM]
Tina Pappas, a managing director with boutique investment bank Morgan Joseph & Co., weighs in on the opportunities for private equity investors interested in getting into the special purpose acquisition
Continue reading
|
|
Browse other archives
« Soapbox: January 2008 |
Home
| Soapbox: March 2008 »
Categories
Blog roll
Archives
|
